Misses and near misses in diagnosing nodular fasciitis and morphologically related reactive myofibroblastic proliferations: experience of a referral center with emphasis on frequency of USP6 gene rearrangements

Original Article

Abstract

Although harmless, reactive and benign neoplastic myo-/fibroblastic proliferations represent a diagnostic challenge in routine surgical pathology practice as reflected by their frequency among consultation cases. In addition to resembling each other, the prototypical nodular fasciitis (NF) and NF-like lesions can be mistaken for low-grade or aggressive sarcomas. USP6 translocation was reported recently as the molecular driver and potential diagnostic marker of NF. We reviewed 71 lesions with a diagnosis of NF (n = 48) or NF-like myofibroblastic proliferations (n = 23) and screened them for USP6 translocation by fluorescence in situ hybridization (FISH). Only one third of NFs were correctly diagnosed by submitting pathologists while one third was initially judged as malignant. NF was mentioned in the differential diagnosis in only half of the cases. A high Ki67/mitotic index, misleading immunohistochemistry (false-positive h-caldesmon), and unusual sites/circumscription were main causes behind overdiagnosis as malignant. FISH analysis revealed USP6 translocation in 74.4% of NF cases. None of the reactive/reparative myofibroblastic proliferations showed USP6 translocation. NF is still significantly misdiagnosed by general surgical pathologists, with a higher tendency toward overdiagnosis of malignancy. Inclusion of NF in the differential diagnosis of any fibromyxoid soft tissue lesion and awareness of its diverse morphology are mandatory to avoid misdiagnoses with the risk of disastrous overtreatment. In the appropriate clinicopathological context, USP6 gene translocation is a valuable adjunct for diagnosis of NF, particularly in limited biopsies. Absence of the USP6 gene translocation in NF-like reparative pseudosarcomatous myofibroblastic proliferations underlines their reactive nature and distinguishes them from NF which is currently considered a benign neoplasm with a self-limiting “transient” growth phase.

Keywords

Myxofibrosarcoma USP6 translocation Nodular fasciitis Myositis ossificans Heterotopic ossification Sarcoma Proliferative fasciitis Myofibroblastic sarcoma Fibroma of tendon sheath 

Notes

Acknowledgements

We thank our technicians Susanne Blank and Natascha Leicht as well as Corinna Eisele for technical support.

Compliance with ethical standards

Ethical approval

All procedures performed in this retrospective data analysis involving human participants were in accordance with the ethical standards of the institutional review board, which did not require informed consent. Approval of the local academic ethics committee of the University of Erlangen was obtained (ref. number 28_18Bc).

Conflict of interest

The authors declare that they have no conflicts of interest.

References

  1. 1.
    Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F (eds) (2013) WHO classification of tumours of soft tissue and bone. IARC, Lyon [Lyon]Google Scholar
  2. 2.
    Allen PW (1972) Nodular fasciitis and its variants. Pathology 4(1):61CrossRefGoogle Scholar
  3. 3.
    Shimizu S, Hashimoto H, Enjoji M (1984) Nodular fasciitis: an analysis of 250 patients. Pathology 16(2):161–166CrossRefPubMedGoogle Scholar
  4. 4.
    Thompson LD, Fanburg-Smith JC, Wenig BM (2001) Nodular fasciitis of the external ear region: a clinicopathologic study of 50 cases. Ann Diagn Pathol 5(4):191–198CrossRefPubMedGoogle Scholar
  5. 5.
    O'Connell JX et al (1997) Nodular fasciitis of the vulva: a study of six cases and literature review. Int J Gynecol Pathol 16(2):117–123CrossRefPubMedGoogle Scholar
  6. 6.
    de Feraudy S, Fletcher CD (2010) Intradermal nodular fasciitis: a rare lesion analyzed in a series of 24 cases. Am J Surg Pathol 34(9):1377–1381CrossRefPubMedGoogle Scholar
  7. 7.
    Hornick JL, Fletcher CD (2006) Intraarticular nodular fasciitis—a rare lesion: clinicopathologic analysis of a series. Am J Surg Pathol 30(2):237–241CrossRefPubMedGoogle Scholar
  8. 8.
    Eversole LR et al (1999) Nodular fasciitis and solitary fibrous tumor of the oral region: tumors of fibroblast heterogeneity. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 87(4):471–476CrossRefPubMedGoogle Scholar
  9. 9.
    Chung EB, Enzinger FM (1975) Proliferative fasciitis. Cancer 36(4):1450–1458CrossRefPubMedGoogle Scholar
  10. 10.
    Meis JM, Enzinger FM (1992) Proliferative fasciitis and myositis of childhood. Am J Surg Pathol 16(4):364–372CrossRefPubMedGoogle Scholar
  11. 11.
    Magro G, Michal M, Alaggio R, D’ Amore E (2011) Intradermal proliferative fasciitis in childhood: a potential diagnostic pitfall. J Cutan Pathol 38(1):59–62CrossRefPubMedGoogle Scholar
  12. 12.
    Kwittken J, Branche M (1969) Fasciitis ossificans. Am J Clin Pathol 51(2):251–255CrossRefPubMedGoogle Scholar
  13. 13.
    Daroca PJ Jr, Pulitzer DR, LoCicero J 3rd (1982) Ossifying fasciitis. Arch Pathol Lab Med 106(13):682–685PubMedGoogle Scholar
  14. 14.
    Funakoshi Y, Chou MM, Kanaho Y, Donaldson JG (2014) TRE17/USP6 regulates ubiquitylation and trafficking of cargo proteins that enter cells by clathrin-independent endocytosis. J Cell Sci 127(21):4750–4761CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Oliveira AM, Chou MM (2014) USP6-induced neoplasms: the biologic spectrum of aneurysmal bone cyst and nodular fasciitis. Hum Pathol 45(1):1–11CrossRefPubMedGoogle Scholar
  16. 16.
    Oliveira AM, Hsi BL, Weremowicz S, Rosenberg AE, Cin PD, Joseph N, Bridge JA, Perez-Atayde AR, Fletcher JA (2004) USP6 (Tre2) fusion oncogenes in aneurysmal bone cyst. Cancer Res 64(6):1920–1923CrossRefPubMedGoogle Scholar
  17. 17.
    Oliveira AM, Perez-Atayde AR, Inwards CY, Medeiros F, Derr V, Hsi BL, Gebhardt MC, Rosenberg AE, Fletcher JA (2004) USP6 and CDH11 oncogenes identify the neoplastic cell in primary aneurysmal bone cysts and are absent in so-called secondary aneurysmal bone cysts. Am J Pathol 165(5):1773–1780CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Erickson-Johnson MR, Chou MM, Evers BR, Roth CW, Seys AR, Jin L, Ye Y, Lau AW, Wang X, Oliveira AM (2011) Nodular fasciitis: a novel model of transient neoplasia induced by MYH9-USP6 gene fusion. Lab Investig 91(10):1427–1433CrossRefPubMedGoogle Scholar
  19. 19.
    Kumar E, Patel NR, Demicco EG, Bovee JVMG, Olivera AM, Lopez-Terrada DH, Billings SD, Lazar AJ, Wang WL (2016) Cutaneous nodular fasciitis with genetic analysis: a case series. J Cutan Pathol 43(12):1143–1149CrossRefPubMedGoogle Scholar
  20. 20.
    Chung EB, Enzinger FM (1979) Fibroma of tendon sheath. Cancer 44(5):1945–1954CrossRefPubMedGoogle Scholar
  21. 21.
    Carter JM, Wang X, Dong J, Westendorf J, Chou MM, Oliveira AM (2016) USP6 genetic rearrangements in cellular fibroma of tendon sheath. Mod Pathol 29(8):865–869CrossRefPubMedGoogle Scholar
  22. 22.
    Hansen T, Katenkamp K, Katenkamp D (2006) Intramuscular nodular fasciitis—a clinicopathological study with emphasis on myogenic giant cells. Pathologe 27(3):198–203CrossRefPubMedGoogle Scholar
  23. 23.
    Amaranathan A et al (2016) Giant intramuscular nodular fasciitis masquerading as soft tissue sarcoma with neural involvement—a case report. J Clin Diagn Res 10(6):Pd13–Pd15PubMedPubMedCentralGoogle Scholar
  24. 24.
    Amary MF, Ye H, Berisha F, Tirabosco R, Presneau N, Flanagan AM (2013) Detection of USP6 gene rearrangement in nodular fasciitis: an important diagnostic tool. Virchows Arch 463(1):97–98CrossRefPubMedGoogle Scholar
  25. 25.
    Perez-Montiel MD, Plaza JA, Dominguez-Malagon H, Suster S (2006 Apr) Differential expression of smooth muscle myosin, smooth muscle actin, h-caldesmon, and calponin in the diagnosis of myofibroblastic and smooth muscle lesions of skin and soft tissue. Am J Dermatopathol 28(2):105–111CrossRefPubMedGoogle Scholar
  26. 26.
    Shin C, Low I, Ng D, Oei P, Miles C, Symmans P (2016) USP6 gene rearrangement in nodular fasciitis and histological mimics. Histopathology 69(5):784–791CrossRefPubMedGoogle Scholar
  27. 27.
    Patel NR, Chrisinger JSA, Demicco EG, Sarabia SF, Reuther J, Kumar E, Oliveira AM, Billings SD, Bovée JVMG, Roy A, Lazar AJ, Lopez-Terrada DH, Wang WL (2017) USP6 activation in nodular fasciitis by promoter-swapping gene fusions. Mod Pathol 30(11):1577–1588CrossRefPubMedGoogle Scholar
  28. 28.
    Guo R, Wang X, Chou MM, Asmann Y, Wenger DE, al-Ibraheemi A, Molavi DW, Aboulafia A, Jin L, Fritchie K, Oliveira JL, Jenkins RB, Westendorf JJ, Dong J, Oliveira AM (2016) PPP6R3-USP6 amplification: novel oncogenic mechanism in malignant nodular fasciitis. Genes Chromosomes Cancer 55(8):640–649CrossRefPubMedGoogle Scholar
  29. 29.
    Chaudhry IH, Kazakov DV, Michal M, Mentzel T, Luzar B, Calonje E (2010) Fibro-osseous pseudotumor of the digit: a clinicopathological study of 17 cases. J Cutan Pathol 37(3):323–329CrossRefPubMedGoogle Scholar
  30. 30.
    Sukov WR, Franco MF, Erickson-Johnson M, Chou MM, Unni KK, Wenger DE, Wang X, Oliveira AM (2008) Frequency of USP6 rearrangements in myositis ossificans, brown tumor, and cherubism: molecular cytogenetic evidence that a subset of “myositis ossificans-like lesions” are the early phases in the formation of soft-tissue aneurysmal bone cyst. Skelet Radiol 37(4):321–327CrossRefGoogle Scholar
  31. 31.
    Bekers EM, Eijkelenboom A, Grünberg K, Roverts RC, de Rooy JWJ, van der Geest ICM, van Gorp JM, Creytens D, Flucke U (2018) Myositis ossificans—another condition with USP6 rearrangement, providing evidence of a relationship with nodular fasciitis and aneurysmal bone cyst. Ann Diagn Pathol 34:56–59CrossRefGoogle Scholar
  32. 32.
    Allen PW, Allen LJ (1994) Perce the permissive pathologist: a cautionary tale of one who misdiagnosed a pseudosarcoma, killed the patient and was found out. Aust N Z J Surg 64(4):273–274CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Institute of PathologyFriedrich-Alexander University Erlangen-Nürnberg (FAU)ErlangenGermany

Personalised recommendations